Form 4: Odyssey Health COO Gregory Gironda Awarded Stock Options

Gregory Gironda, Chief Operating Officer of Odyssey Health, Inc., was granted stock options to purchase 250,000 shares of common stock.

Summary

• On June 28, 2024, Gregory W. Gironda, the Chief Operating Officer of Odyssey Health, Inc. (ODYY), was granted stock options.
• These options allow him to purchase 250,000 shares of the company's common stock at an exercise price of $0.10 per share.
• The options vest in installments: 50,000 immediately, and then 50,000 on July 31, 2024, October 31, 2024, January 31, 2025, and April 30, 2025.
• The options expire on June 27, 2034.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The granting of stock options is a standard practice and suggests confidence in the executive's ability to contribute to the company's success. There are no explicitly negative aspects in the filing.

Positives

• The granting of stock options to the COO aligns his interests with those of the shareholders.
• The vesting schedule incentivizes continued service and contribution to the company's success.

Future Outlook

The document does not contain any specific forward-looking statements beyond the vesting schedule of the options.

Industry Context

Granting stock options to executives is a common practice in the healthcare industry to incentivize performance and align management's interests with those of shareholders. The size and vesting schedule of the options are typical for executive compensation packages.

Comparison to Industry Standards

• Stock option grants are a standard component of executive compensation packages across various industries, including healthcare.
• Companies like Amgen, Gilead Sciences, and Biogen also utilize stock options as part of their executive compensation plans.
• The vesting schedules and exercise prices are generally determined based on company performance, industry benchmarks, and individual contributions.

Stakeholder Impact

• Shareholders may view the granting of stock options positively as it aligns management's interests with the company's long-term success.
• Employees may see this as a positive sign of the company's commitment to its leadership.

Key Dates

Keywords

stock options, Odyssey Health, ODYY, Gregory Gironda, COO, insider transaction, Form 4, equity compensation, vesting